产品
编 号：F170266
分子式：C6H16N4O2
分子量：176.22
分子式：C6H16N4O2
分子量：176.22
产品类型
规格
价格
是否有货
5mg
询价
询价
10mg
询价
询价
25mg
询价
询价
50mg
询价
询价
结构图
CAS No: 146672-58-4
产品详情
生物活性：
PAPA NONOate is a NO donor with a NO release half-life of 77 min (22-25°C). PAPA NONOate may represent a potential research for impaired wound healing in diabetes by increasing the rate of collagen synthesis at the wound site.
体内研究：
PAPA NONOate (100 μM in phosphate buffer) increases the rate of wound healing in rats with diabetes and wound.Animal Model:Anesthetized male Sprague-Dawley rats with streptozotocin-induced diabetes and full thickness dermal wound
Dosage:100 μM
Administration:Wounds received 100 μM PAPA NONOate in phosphate buffer
Result:Increased the wound healing rate in test group.
体外研究：
PAPA NONOate (50 μM; 12 h) significantly reduces 70% caspase-3-like activity in caspase-3-overexpressing HUVEC and abolishs the induction of cell death by caspase-3.
PAPA NONOate is a NO donor with a NO release half-life of 77 min (22-25°C). PAPA NONOate may represent a potential research for impaired wound healing in diabetes by increasing the rate of collagen synthesis at the wound site.
体内研究：
PAPA NONOate (100 μM in phosphate buffer) increases the rate of wound healing in rats with diabetes and wound.Animal Model:Anesthetized male Sprague-Dawley rats with streptozotocin-induced diabetes and full thickness dermal wound
Dosage:100 μM
Administration:Wounds received 100 μM PAPA NONOate in phosphate buffer
Result:Increased the wound healing rate in test group.
体外研究：
PAPA NONOate (50 μM; 12 h) significantly reduces 70% caspase-3-like activity in caspase-3-overexpressing HUVEC and abolishs the induction of cell death by caspase-3.
产品资料
Copyright©2015-2024 沪ICP备2022026524号-1
沪公网安备